Literature DB >> 23286587

Increased frequency of CD8+ and CD4+ regulatory T cells in chronic lymphocytic leukemia: association with disease progression.

Farhad Jadidi-Niaragh1, Mehdi Yousefi, Ali Memarian, Mohammad Hojjat-Farsangi, Jalal Khoshnoodi, Seyed Mohsen Razavi, Mahmood Jeddi-Tehrani, Fazel Shokri.   

Abstract

Little is known regarding the immunobiology of regulatory T (Treg) cells in hematopoietic malignancies, particularly in chronic lymphocytic leukemia (CLL). In the present study, we showed that the frequencies of CD8(+) and CD4(+) Treg cells were significantly increased in progressive as compared with indolent CLL patients and normal subjects. Enriched CD4(+) Treg cells induced a similar level of inhibition in polyclonally activated B cells and effector T cells from CLL patients and normal subjects. Our results suggest that the increase in circulating Treg cells may result in downregulation of tumor-specific immune response, leading to tumor expansion and disease progression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23286587     DOI: 10.3109/07357907.2012.756110

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  22 in total

1.  Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL.

Authors:  Gonzalo Blanco; Anna Vardi; Anna Puiggros; Andrea Gómez-Llonín; Manuel Muro; María Rodríguez-Rivera; Evangelia Stalika; Eugenia Abella; Eva Gimeno; Manuela López-Sánchez; Alicia Senín; Xavier Calvo; Pau Abrisqueta; Francesc Bosch; Ana Ferrer; Kostas Stamatopoulos; Blanca Espinet
Journal:  Oncoimmunology       Date:  2018-02-20       Impact factor: 8.110

Review 2.  Blinatumomab: enlisting serial killer T-cells in the war against hematologic malignancies.

Authors:  Britny Rogala; Craig W Freyer; Evelena P Ontiveros; Elizabeth A Griffiths; Eunice S Wang; Meir Wetzler
Journal:  Expert Opin Biol Ther       Date:  2015-06       Impact factor: 4.388

3.  The regulatory capacity of B cells directs the aggressiveness of CLL.

Authors:  Audrey Mohr; Marie Cumin; Cristina Bagacean; Pierre Pochard; Christelle Le Dantec; Sophie Hillion; Yves Renaudineau; Christian Berthou; Adrian Tempescul; Hussam Saad; Jacques-Olivier Pers; Anne Bordron; Christophe Jamin
Journal:  Oncoimmunology       Date:  2018-12-12       Impact factor: 8.110

Review 4.  The immunobiology of myeloid-derived suppressor cells in cancer.

Authors:  Morteza Motallebnezhad; Farhad Jadidi-Niaragh; Elmira Safaie Qamsari; Salman Bagheri; Tohid Gharibi; Mehdi Yousefi
Journal:  Tumour Biol       Date:  2015-11-26

Review 5.  Regulatory B lymphocyte functions should be considered in chronic lymphocytic leukemia.

Authors:  Audrey Mohr; Yves Renaudineau; Cristina Bagacean; Jacques-Olivier Pers; Christophe Jamin; Anne Bordron
Journal:  Oncoimmunology       Date:  2016-03-16       Impact factor: 8.110

6.  Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles.

Authors:  Farhad Jadidi-Niaragh; Fatemeh Atyabi; Ali Rastegari; Esmail Mollarazi; Melika Kiani; Alireza Razavi; Mehdi Yousefi; Nasim Kheshtchin; Hadi Hassannia; Jamshid Hadjati; Fazel Shokri
Journal:  Tumour Biol       Date:  2016-01-05

Review 7.  Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions.

Authors:  Farhad Jadidi-Niaragh; Ghasem Ghalamfarsa; Mehdi Yousefi; Mina Hajifaraj Tabrizi; Fazel Shokri
Journal:  Tumour Biol       Date:  2013-05-17

Review 8.  Myeloid-derived suppressor cells in B cell malignancies.

Authors:  Yaghoub Yazdani; Mousa Mohammadnia-Afrouzi; Mehdi Yousefi; Enayat Anvari; Ghasem Ghalamfarsa; Hadi Hasannia; Sanam Sadreddini; Farhad Jadidi-Niaragh
Journal:  Tumour Biol       Date:  2015-09-02

9.  Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine.

Authors:  Hadi Hassannia; Mitra Ghasemi Chaleshtari; Fatemeh Atyabi; Mahshid Nosouhian; Ali Masjedi; Mohammad Hojjat-Farsangi; Afshin Namdar; Gholamreza Azizi; Hamed Mohammadi; Ghasem Ghalamfarsa; Gholamabas Sabz; Sajad Hasanzadeh; Mehdi Yousefi; Farhad Jadidi-Niaragh
Journal:  Immunology       Date:  2019-10-24       Impact factor: 7.397

10.  Different T cell related immunological profiles in COVID-19 patients compared to healthy controls.

Authors:  Armin Mahmoud Salehi Khesht; Vahid Karpisheh; Balsam Qubais Saeed; Angelina Olegovna Zekiy; Lis M Yapanto; Mohsen Nabi Afjadi; Mohsen Aksoun; Maryam Nasr Esfahani; Fatemeh Aghakhani; Mahsa Movahed; Navneet Joshi; Kazem Abbaszadeh-Goudarzi; Shahin Hallaj; Majid Ahmadi; Sanam Dolati; Ata Mahmoodpoor; Vida Hashemi; Farhad Jadidi-Niaragh
Journal:  Int Immunopharmacol       Date:  2021-05-28       Impact factor: 5.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.